THIS INVENTION REFERS TO THE DIAGNOSIS OF THE CONGENITE DEFECT IN THE ANTICOAGULATING SYSTEM OF PROTEIN C. THE DESCRIBED METHODS ARE BASED ON THE DETECTION OF MUTATIONS IN THE DIVISION SITES OF THE COAGULATION FACTORS THAT ARE UNDER CONTROL OF THE PROTEIN C ACTIVATED ( . DIAGNOSTIC TESTS ...